Xeris Biopharma Holdings, Inc. (XERS) Cash Flow Annual - Discounting Cash Flows
XERS
Xeris Biopharma Holdings, Inc.
XERS (NASDAQ)
Period Ending: LTM
(Last Twelve Months)
2024
12-31
2023
12-31
2022
12-31
2021
12-31
2020
12-31
2019
12-31
2018
12-31
2017
12-31
2016
12-31
Report Filing: 2025-11-06 2025-03-06 2024-03-06 2023-03-08 2022-03-11 2022-03-11 2020-12-31 2019-03-06 2017-12-31 2016-12-31
Net Income/Starting Line -15.64 -54.84 -62.26 -94.66 -122.7 -91.14 -91.14 -60.08 -26.55 -13.21
Cash From Operating Activities 10.56 -36.98 -47.02 -102.9 -95.53 -80.56 -80.56 -56.28 -24.66 -16.09
Depreciation and Amortization 12.24 12.62 13.16 12.67 1.88 1.47 1.47 0.32 0.177 0.116
Deferred Income Tax 0 -2.27 -1.25 -1.42 -1.42 1.11 0.536 -0.414 0 0
Stock Based Compensation 20.69 18.36 10.72 12.16 11.38 8.27 6.48 1.73 0.499 0.54
Other Non-Cash Items 3.73 -2.04 -1.1 3.52 3.5 0.039 4.89 0.56 0.094 0.049
Changes in Working Capital -10.46 -8.82 -6.29 -35.15 11.85 -0.312 -2.8 1.61 1.12 -3.58
Accounts Receivable -12.61 -1.22 -8.37 -13.37 -13.37 -6.24 -2.18 -1.67 -1.1 0.204
Inventory -18.41 -8.78 -14.8 -7.46 -7.46 -7.42 -5.14 4.04 1.7 -0.846
Accounts Payable -3.57 -9.61 6.96 -4.32 -4.32 5.53 -2.49 -1.11 0.661 -2.91
Deferred Revenue 24.14 10.79 9.92 -9.99 19.98 7.01 7.01 0.345 -0.14 -0.032
Other Working Capital 0 0 0 0 17.03 0.803 0 0 0 0
Cash From Investing Activities 9.65 4.88 -6 34.46 34.46 -27.41 -27.41 -68.26 -0.7 -0.035
Investments in Property Plant and Equipment -0.583 -0.868 -2.26 -0.524 -0.524 -0.377 -0.377 -1.51 -0.7 -0.035
Payments for Acquisitions 0 0 0 0 38.47 0 0.377 0 0 0
Purchases of Securities 0 -34.48 -43.74 0 -43.02 -101.8 -101.8 -68.85 0 0
Sales and Maturities of Investments 10.24 40.24 40 34.98 34.98 74.75 74.75 2.1 0 0
Other Investing Activities 0 0 0 0 4.55 0 -0.377 -66.75 0 0
Cash From Financing Activities 12.05 36.17 -1.61 127.5 27.25 126.1 126.1 128.2 35.14 3.9
Debt Repayment 0 38.17 0 102.7 0 69.75 25 35 0 -0.032
Common Stock Issued 14.33 0 0.581 30 27 65.89 61.69 98.33 0.159 0.071
Common Stock Repurchased -0.644 -3.73 -1.01 -0.468 -0.534 -0.063 0 0 0 0
Dividends Paid 0 0 0 0 0 0 0 0 0 0
Other Financing Activities 5.42 1.73 -0.604 -4.78 0 -9.51 101.1 4.11 35.14 3.94
Effect of Forex Changes on Cash 0 0 0 -4.35 -0.003 -0.003 -0.022 0 0 0
Net Change in Cash 19.88 4.07 -54.64 59.04 59.04 29.67 18.08 3.67 9.78 -12.22
Cash at Beginning of Period 75.74 71.67 126.3 67.27 67.27 37.6 19.52 42.05 32.27 44.49
Cash at End of Period 95.62 75.74 71.67 126.3 126.3 67.27 37.6 45.72 42.05 32.27
Free Cash Flow 19.82 -37.85 -49.29 -103.4 -103.4 -96.62 -80.94 -57.79 -25.36 -16.12
Operating Cash Flow 10.56 -36.98 -47.02 -102.9 -102.9 -95.53 -80.56 -56.28 -24.66 -16.09
Capital Expenditure -0.583 -0.868 -2.26 -0.524 -0.524 -1.08 -0.377 -1.51 -0.7 -0.035
discounting cash flows home logo

Discounting Cash Flows

Are you finding our services helpful? Review us on trustpilot logo Trustpilot
Have a question? Contact us
Want to become our sponsor?
Check out our Affiliate Program